| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |